These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33745336)

  • 1. Nexus between COVID-19 and periodontal disease.
    Sukumar K; Tadepalli A
    J Int Med Res; 2021 Mar; 49(3):3000605211002695. PubMed ID: 33745336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model.
    Yuan L; Zhu H; Wu K; Zhou M; Ma J; Chen R; Tang Q; Cheng T; Guan Y; Xia N
    Signal Transduct Target Ther; 2022 Feb; 7(1):47. PubMed ID: 35165265
    [No Abstract]   [Full Text] [Related]  

  • 3. An Impaired Inflammatory and Innate Immune Response in COVID-19.
    Park SH
    Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
    Lee W; Ahn JH; Park HH; Kim HN; Kim H; Yoo Y; Shin H; Hong KS; Jang JG; Park CG; Choi EY; Bae JS; Seo YK
    Signal Transduct Target Ther; 2020 Sep; 5(1):186. PubMed ID: 32883951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 7. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
    Cabler SS; French AR; Orvedahl A
    Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
    Yeleswaram S; Smith P; Burn T; Covington M; Juvekar A; Li Y; Squier P; Langmuir P
    Clin Immunol; 2020 Sep; 218():108517. PubMed ID: 32585295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.
    Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X
    mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
    Lu L; Zhang H; Dauphars DJ; He YW
    Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
    Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D
    Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
    Obando-Pereda G
    J Med Virol; 2021 Sep; 93(9):5350-5357. PubMed ID: 33913542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
    Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
    Front Immunol; 2020; 11():607734. PubMed ID: 33569053
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and the nicotinic cholinergic system in COVID-19.
    Tizabi Y; Getachew B; Copeland RL; Aschner M
    FEBS J; 2020 Sep; 287(17):3656-3663. PubMed ID: 32790936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.